Aspect Biosystems

Tamer Mohamed, Ph.D., Founder and CEO

Oct. 14 | 11:00am | BlueRock Therapeutics Ballroom

Vancouver, Canada

In-person Presentation
Aspect Biosystems is a biotechnology company creating bioprinted therapeutics as medicines of the future. Aspect is applying its microfluidic 3D bioprinting technology internally to develop these advanced cell therapies, and partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.

By using this website you agree to accept our Privacy Policy and Terms & Conditions